BTIG analyst Robert Hazlett maintains Homology Medicines (NASDAQ: FIXX) with a Buy and lowers the price target from $29 to $12.BTIG analyst Robert Hazlett maintains Homology Medicines (NASDAQ:FIXX) with a Buy and lowers the price target from $29 to $
HC Wainwright & Co. cut the price target on Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) from $10 to $5. HC Wainwright & Co. analyst Patrick Trucchio maintained the stock with a Buy rating. Mind Medicine shares rose 2.3% to $0.7164 in pre-market trading.
Benchmark analyst Daniel Kurnos maintains CuriosityStream (NASDAQ: CURI) with a Buy and lowers the price target from $10 to $8.Benchmark analyst Daniel Kurnos maintains CuriosityStream (NASDAQ:CURI) with a Buy and lowers the price target from $10 to
HUYA Inc (NYSE:HUYA) reported a second-quarter FY22 revenue decline of 23.2% year-on-year to $339.68 million, beating the consensus of $335.88 million.…
MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that it plans to participate in RECLAIM (Recovering from COVID-19 Lingering Symptoms Adaptive Integrative Medicine Trial), a grant-funded, multi-
Zedge, Inc. (NYSE AMERICAN: ZDGE), a leader in building marketplaces and games around digital content that enable self-expression, today announced that its Board of Directors authorized a share repurchase program permitting the Company to purchase up to an aggregate of 1.5 million shares of Class B common stock.
Swedish fashion giant Hennes & Mauritz (OTC: HNNMY) has reopened its official store on Alibaba Group Holding’s (NYSE: BABA) Tmall months after the Chinese e-commerce platform took it down over the